Australia's Lumos Diagnostics jumps on distribution expansion

Lumos Diagnostics Holdings

04/07/2024 02:10

** Shares of Lumos Diagnostics  LDX.AX  rise as much as 9.7%
to A$0.034
    ** Healthcare co says it is expanding its distribution
partnership with regional healthcare group Henry Schein's
medical business in Australia and New Zealand
    ** Expansion will make LDX's rapid point-of-care test
FebriDx available to healthcare practitioners in Australia and
New Zealand 
    ** Stock fell for the fifth straight month until June 
    ** LDX down 57.5% YTD, as of last close

 (Reporting by Adwitiya Srivastava in Bengaluru)
 ((Adwitiya.Srivastava@thomsonreuters.com;))